A study undertaken in 2016 in Canada–a country with the highest incidence of MS worldwide–shows that, for the most part, Canadians with MS are, at the very least, open to the idea of cannabidiols. With 54.3% of participants approving of cannabis use, 33.2% remaining neutral, 19.5% of participants using cannabis, and 50.2% of the remaining